Trans-catheter aortic valve replacement can improve outcomes in low-risk surgical patients

May 06, 2019

TORONTO - May 6, 2019 - For patients with aortic stenosis that cannot be treated with medication, surgical (SAVR) and transcatheter (TAVR) aortic valve replacement can offer effective treatment. A new study, one of two on the topic released today at the American Association for Thoracic Surgery's 99th Annual Meeting, examines, for the first time, the effects of TAVR with a balloon-expandable valve for low-risk patients.

950 patients with severe symptomatic aortic stenosis and low surgical risk participated in the randomized trial. At 30 days, results favored TAVR with a balloon-expandable valve, with fewer deaths (0.4 percent vs. 1.1 percent); fewer strokes (0.6 percent vs. 2.4 percent); and fewer re-hospitalizations (3.4 percent vs. 6.5 percent.) These differences were maintained at one year. In addition, 30-day rates of life-threatening bleeding were lower (3.6 percent vs. 24.5 percent), as was new onset atrial fibrillation (5.0 percent vs. 29.5 percent.)

Patients treated with TAVR also experienced other benefits. Length of stay in the ICU and duration of hospital stay were both significantly decreased, with 96 percent of those treated with TAVR discharged to home or self-care vs. 73 percent of SAVR patients.

"While previous studies have focused on patients with higher surgical risk, almost 80 percent of patients who are operated upon for aortic stenosis fall into the low risk category," explained lead author Martin Leon, Director, Center for Interventional Vascular Therapy at New York-Presbyterian/ Columbia University Medical Center and Founder and Chairman Emeritus of the Cardiovascular Research Foundation (CRF). "Significantly, the data shows that for low risk patients, the two therapies - SAVR and TAVR - are at least equivalent, and in many cases, TAVR may be the preferred alternative. The study will continue to follow patients to 10 years, which will also provide important data on the durability of these balloon expandable valves."
-end-
Notes for Editors:

The PARTNER 3 Low-Risk TAVR Trial: Detailed Analysis of Primary Endpoint Components and Key Secondary Endpoints

Martin B. Leon, Michael J. Mack, Maria C. Alu, Raj Makkar, Vinod Thourani, Susheel Kodali, Samir Kapadia, Wilson Szeto, Mark Russo, Mathew R. Williams, S. Chris Malaisrie, Philippe Pibarot, Scott Goldman, John Webb, David J. Cohen, and Craig R. Smith

Presented by Martin Leon, MD, Monday, May 6, 2019 at the AATS 99th Annual Meeting.

ABOUT THE AMERICAN ASSOCIATION FOR THORACIC SURGERY (AATS)

The American Association for Thoracic Surgery (AATS) is an international organization that encourages, promotes, and stimulates the scientific investigation of cardiothoracic surgery. Founded in 1917 by a respected group of the earliest pioneers in the field, its original mission was to "foster the evolution of an interest in surgery of the Thorax." Today, the AATS is the premiere association for cardiothoracic surgeons in the world and works to continually enhance the ability of cardiothoracic surgeons to provide the highest quality of patient care. Its more than 1500 members have a proven record of distinction within the specialty and have made significant contributions to the care and treatment of cardiothoracic disease. Visit http://www.aats.org to learn more.

American Association for Thoracic Surgery

Related Aortic Valve Replacement Articles from Brightsurf:

Aortic valve replacement during COVID-19 pandemic
The outcomes associated with deferred compared with expedited aortic valve replacement in patients with severe aortic stenosis during the COVID-19 pandemic are evaluated in this observational study.

Patients deferred for transcatheter aortic valve replacement because of COVID-19
This single-center study of 77 patients describes the outcomes of patients with symptomatic severe aortic stenosis during the COVID-19 pandemic.

World's first minimally invasive tricuspid valve replacement performed in Toronto
The world's first minimally invasive tricuspid valve replacement was performed at St.

Research reveals link between high cholesterol levels and risk of aortic valve disease
Researchers from The George Institute for Global Health at the University of Oxford have found that while having high cholesterol levels does not influence your risk of aortic or mitral valve regurgitation, it does increase your risk of developing another major heart valve disease -- aortic stenosis.

New type of heart valve may be the only replacement a child needs
Current prosthetic heart valves for children with congenital heart disease are fixed in size, requiring repeated open-heart surgeries during childhood to replace the valve with a larger version.

NEJM: transcatheter aortic valve replacement shows similar safety outcomes as open-heart surgery
A new study from the Smidt Heart Institute at Cedars-Sinai and other centers nationwide shows that patients who underwent a minimally invasive transcatheter aortic-valve replacement (TAVR), had similar key 5-year clinical outcomes of death and stroke as patients who had traditional open-heart surgery to replace the valve.

Young age does not equal low risk for patients needing aortic valve replacement
While transcatheter aortic valve replacement (TAVR) continues to expand its pool of eligible patients, open heart surgery -- resulting in excellent patient survival and fewer strokes when compared to TAVR--is the best option for young and middle-aged adults with aortic valve disease -- at least for now.

Public reporting on aortic valve surgeries has decreased access, study finds
Public reporting on aortic valve replacement outcomes has resulted in fewer valve surgeries for people with endocarditis, a new study has found.

Bioengineers explore cardiac tissue remodeling after aortic valve replacement procedures
Researchers have developed biomaterial-based 'mimics' of heart tissues to measure patients' responses to an aortic valve replacement procedure, offering new insight into the ways that cardiac tissue re-shapes itself post-surgery.

New research addresses incidence of atrial fibrillation after aortic valve replacement
UAB investigators have outlined the incidence and implications of atrial fibrillation after transcatheter aortic valve implantation and surgical aortic valve replacement.

Read More: Aortic Valve Replacement News and Aortic Valve Replacement Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.